Clinical Profile and Intra-Hospital Outcomes of Peripartum Cardiomyopathy in Ibadan, Nigeria
- PMID: 40584792
- PMCID: PMC12205104
- DOI: 10.1007/s13224-025-02116-6
Clinical Profile and Intra-Hospital Outcomes of Peripartum Cardiomyopathy in Ibadan, Nigeria
Abstract
Aim: The clinical profile of the disease in southern Nigeria is less reported. This study aims to describe the clinical characteristics and intra-hospital outcomes of PPCM in Ibadan, south-west Nigeria.
Materials and methods: We reviewed 69 cases of PPCM seen in Nigerian Women at the University College Hospital Ibadan between 2006 and 2021.
Results: The mean age at presentation was 30.5 ± 6.7 years (age range 18 - 46 years). The mean BMI was 23.5 kg/M2. Most were from the low socio-economic group (47/68.1%) and presented postpartum. The majority were primipara; twin pregnancy was seen in four (5.8%), and PIH occurred in 10 (14.5%) cases. Heart failure was the most typical mode of presentation. Over 90% of the women had spontaneous vertex delivery. Fetal death was recorded in three (4.3%). Two women died. Both presented with severe heart failure and died within few days on admission.
Conclusion: PPCM in Ibadan, Nigeria, is relatively a disease of primipara from poor homes and in unbooked pregnant women. Improvement in maternal health will be invaluable in prevention of the condition in Nigeria.
Keywords: Cardiomyopathy; Heart failure; Peripartum cardiomyopathy; Pregnancy.
© The Author(s) 2025.
Conflict of interest statement
Conflict of interestAuthors declare no conflict of interest.
Similar articles
-
Oxytocin for preventing postpartum haemorrhage (PPH) in non-facility birth settings.Cochrane Database Syst Rev. 2016 Apr 14;4(4):CD011491. doi: 10.1002/14651858.CD011491.pub2. Cochrane Database Syst Rev. 2016. PMID: 27078125 Free PMC article.
-
Induction of labour for improving birth outcomes for women at or beyond term.Cochrane Database Syst Rev. 2018 May 9;5(5):CD004945. doi: 10.1002/14651858.CD004945.pub4. Cochrane Database Syst Rev. 2018. Update in: Cochrane Database Syst Rev. 2020 Jul 15;7:CD004945. doi: 10.1002/14651858.CD004945.pub5. PMID: 29741208 Free PMC article. Updated.
-
Home treatment for mental health problems: a systematic review.Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150. Health Technol Assess. 2001. PMID: 11532236
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2020 Jan 9;1:CD011535. doi: 10.1002/14651858.CD011535.pub3. PMID: 29271481 Free PMC article. Updated.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
References
-
- Sliwa K, Hilfiker-Kleiner D, Petrie MC, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the heart failure association of the European society of cardiology working group on peripartum cardiomyopathy. Eur J Heart Fail. 2010;12(8):767–78. 10.1093/eurjhf/hfq120. ((In eng)). - PubMed
-
- Pearson GD, Veille JC, Rahimtoola S, et al. Peripartum cardiomyopathy: national heart, lung, and blood institute and office of rare diseases (national institutes of health) workshop recommendations and review. JAMA. 2000;283(9):1183–8. 10.1001/jama.283.9.1183. ((In eng)). - PubMed
-
- Hilfiker-Kleiner D, Sliwa K. Pathophysiology and epidemiology of peripartum cardiomyopathy. Nat Rev Cardiol. 2014;11(6):364–70. 10.1038/nrcardio.2014.37. ((In eng)). - PubMed